← Leaderboards
Mehrinfar Mahzad
Fisher Bioservices, Inc.
$18,271,500
Attributed
$18,271,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.2M · FY2023–25$10M$7.5M$5M$2.5M$0
'23
'24
'25
Funding mix
By agency
NIH$18,271,500 · 1
By mechanism
N02$18,271,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Fisher Bioservices, Inc.
Same institution · by research overlap
- Oguz Mandaci$12,993,956
- Christopher Parsons$12,507,496
- Brittany Martin$4,767,959
- Hannah Elson$18,807,207
- John Kudrick$40,651,058
Others in their field
Other Rising Stars on “Cancer Therapy Evaluation Program”
- Lauren Miller · Technical Resources International, Inc.$31,120,905
- Walt Lee$25,884,232
- Lucille Patrichuk · Westat, Inc.$5,952,799
- Christine O'Connell · H. Lee Moffitt Cancer Ctr & Res Inst$5,657,016
- Yan Ji · Healthpartners Institute$5,300,768
- Martin Pule · University College London$3,627,871
Research focus
Cancer Therapy Evaluation ProgramClinical DistributionConduct Clinical TrialsContractsContract ServicesDrug DevelopmentPharmaceutical PreparationsPharmacologic SubstanceProgram DevelopmentRepository